Connect with us

Health

GSK says tests show Vir antibody drug works against Omicron

GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with US partner Vir has indicated that the drug also works against the new Omicron variant.

Further tests will be carried out on the sotrovimab therapy to firm up the results, GSK said in a statement.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Moderna exec says company could have Omicron booster ready in March

UAE reports its first case of COVID-19 variant Omicron

Fauci: First US case of COVID-19 omicron variant identified

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

‘Just in case’ use of antibiotics was rife during COVID-19, says UN health agency

Antibiotics saw “extensive overuse” globally among hospitalized COVID-19 patients during the pandemic without improving clinical outcomes, while also potentially exacerbating the already serious and growing threat of antimicrobial resistance, the UN World Health Organization (WHO) said on Friday.

Continue Reading

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Continue Reading

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.

Continue Reading

Trending